Lee, H.J.; Jeong, P.; Moon, Y.; Choi, J.; Heo, J.D.; Kim, Y.-C.; Han, S.-Y.
Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. Pharmaceuticals 2021, 14, 38.
https://doi.org/10.3390/ph14010038
AMA Style
Lee HJ, Jeong P, Moon Y, Choi J, Heo JD, Kim Y-C, Han S-Y.
Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. Pharmaceuticals. 2021; 14(1):38.
https://doi.org/10.3390/ph14010038
Chicago/Turabian Style
Lee, Hyo Jeong, Pyeonghwa Jeong, Yeongyu Moon, Jungil Choi, Jeong Doo Heo, Yong-Chul Kim, and Sun-Young Han.
2021. "Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer" Pharmaceuticals 14, no. 1: 38.
https://doi.org/10.3390/ph14010038
APA Style
Lee, H. J., Jeong, P., Moon, Y., Choi, J., Heo, J. D., Kim, Y.-C., & Han, S.-Y.
(2021). Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. Pharmaceuticals, 14(1), 38.
https://doi.org/10.3390/ph14010038